SXTC: SXT China Quarterly Revenue Growth

Graphic logo of SXT China (SXTC)

The quarterly revenue dynamics history from the GURU.Markets terminal shows that China SXT Pharmaceuticals (SXTC) maintains moderate pricing due to generic competition, while the 0.00 mark reflects the latest data. A shortage of funds limits the company to targeted deals with distributors, ruling out mergers. The business is based on processing rare herbs into modern forms, utilizing unique formulations and strict quality control of raw materials.

SXTC SXT China Sales Growth QoQ (07/04/2022 - 11/20/2026)

Analytical breakdowns for China SXT Pharmaceuticals (SXTC)

- cash and cash movement details:
Fundamental company analysis:China SXT Pharmaceuticals - SXTC
Flagship merchandise of SXT China

By analyzing quarterly changes in sales volume, we assess the market status of China SXT Pharmaceuticals (SXTC) within the traditional medicine sector. This indicator measures revenue growth rates between the current and previous quarters, revealing hidden tail risks and demand dynamics. The metric's high sensitivity to macroeconomics allows for the tracking of cash flow resilience. Inelastic demand for essential medicines ensures steady growth of this indicator and reliable operational FCF.

Direct competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Amneal Pharmaceuticals Inc AMRX|Quarterly Revenue Growth PRGO|Sales Change QoQ ALVO|Quarterly Revenue Growth LQDA (Liquidia Technologies)|Quarterly Revenue Growth Galapagos GLPG|ANI Pharmaceuticals Inc - Quarterly Revenue Growth|MNKD (MannKind Corp.) - Sales Growth QoQ|AMPH: Quarterly Revenue Growth|PCRX (Pacira BioSciences) - Revenue Growth QoQ|Revenue Growth QoQ ARS Pharmaceuticals Inc|Quarterly Sales Growth Theravance Biopharma, Inc. (TBPH)|Quarterly Sales Growth AQST (Aquestive Pharma)|SCPH - Quarterly Revenue Growth Rate|Quarterly Revenue Growth TECX (Tectonic Therapeutic, Inc.)|TNXP - Quarterly Sales Growth|Eupraxia Pharmaceuticals - Quarterly Revenue Growth|Quarterly Sales Growth Rate BioHarvest Sciences Inc. BHST|EXOZ: Quarterly Revenue Growth|Oramed (ORMP) - Quarterly Revenue Growth|ENTX (Entera Bio) - Quarterly Revenue Growth|ipatherapeutics.com (HYFT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Quarterly Revenue Increase|Revenue Growth QoQ Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Quarterly Revenue Growth Rate|TELO: Quarterly Sales Growth|Quarterly Sales Growth Rate Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Revenue Growth QoQ|RLYB - Quarterly Sales Growth Rate|Revenue Growth QoQ Lexaria Bioscience|Pulmatrix Corp - Revenue Dynamics QoQ|Revenue Growth QoQ ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth QoQ|Quarterly Revenue Growth LYRA (Lyra Therapeutics Inc.)|Quarterly Sales Growth Rate Impact BioMedical (IBO)|TNF Pharmaceuticals - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)